USPTO 2015–2025 USPTO PatentsView US Corporation

Valencell, Inc.

USPTO PatentsView assignee record — 105 granted patents across 19 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

105
Total patents granted
19
CPC technology areas
18.7
Avg claims per patent
+50%
5-year filing velocity

The verdict

Valencell holds 105 US patents across 19 technology areas — rank #3,518 of 50,000 tracked assignees.

#3,518
of 50,000 US assignees by volume
Top 22%
by Innovation Score (45.9/100)
18.7
avg claims per patent
+50%
filing velocity, last 5 yrs

Portfolio overview

Valencell, Inc. has been granted 105 US utility patents between 2015 and 2024, placing Valencell, Inc. at rank #3,518 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Valencell, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 45.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 63 grants, compared with 42 in the 2015–2019 window — a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Valencell, Inc.'s 18.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Valencell, Inc. against peers pursuing similar technology classes.

How does Valencell compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Valencell holds 105 patents — placing it at rank #3,518 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Valencell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

0510152025 2015201620172018201920202021202220232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Valencell, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 9.5%
2016 6 5.7%
2017 7 6.7%
2018 7 6.7%
2019 12 11.4%
2020 20 19.0%
2021 19 18.1%
2022 20 19.0%
2023 3 2.9%
2024 1 1.0%

Which technologies does Valencell, Inc. patent most?

Top 15 of 19 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,518

Across all tracked assignees

Innovation Score

45.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Valencell, Inc. hold?
Valencell, Inc. holds 105 US granted patents filed between 2015 and 2024, spanning 19 technology areas.
What is Valencell, Inc.'s Innovation Score?
Valencell, Inc. has an Innovation Score of 45.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Valencell, Inc. focus on?
Valencell, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 101 patents. The company has filed patents in 19 CPC subclasses total.
Is Valencell, Inc.'s patent filing rate increasing or decreasing?
Valencell, Inc.'s recent filing velocity is +50% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Valencell, Inc.'s patents?
Valencell, Inc.'s patents average 18.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Valencell, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Valencell's 105 grants land it in the top 22% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Valencell ranks #3,518 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B — see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov